Viral hemorrhagic fever - Revision history

Aidan: Text replacement - "== Clinical Presentation" to "== Clinical Manifestations"

2020-08-02T13:07:54Z

Text replacement - "== Clinical Presentation" to "== Clinical Manifestations"

← Older revision		Revision as of 13:07, 2 August 2020
Line 53:		Line 53:
	* Hemorrhagic disease results from inflammation causing vasodilatation and increased permeability, rather than viral infection of the endothelium		* Hemorrhagic disease results from inflammation causing vasodilatation and increased permeability, rather than viral infection of the endothelium

	== Clinical ~~Presentation~~ ==		== Clinical Manifestations ==

	* Myriad, from asymptomatic to self-limited fever to fatal		* Myriad, from asymptomatic to self-limited fever to fatal

Aidan: /* Clinical Presentation */

2020-07-05T20:47:42Z

Clinical Presentation

← Older revision		Revision as of 20:47, 5 July 2020
Line 69:		Line 69:
	** They will still be infectious for months after resolution		** They will still be infectious for months after resolution
	** They may have a recurrence or relapse of disease from these sites, which may be limited (e.g. uveitis or meningitis alone)		** They may have a recurrence or relapse of disease from these sites, which may be limited (e.g. uveitis or meningitis alone)

	![Clinical characteristics of selected viral hemorrhagic fevers](VHF clinical characteristics 1.png)

	![Clinical characteristics of selected viral hemorrhagic fevers](VHF clinical characteristics 2.png)

	== Case Definitions ==		== Case Definitions ==

Aidan: /* Epidemiology */

2020-07-05T20:47:34Z

Epidemiology

← Older revision		Revision as of 20:47, 5 July 2020
Line 38:		Line 38:

	== Epidemiology ==		== Epidemiology ==

	![Epidemiology of selected viral hemorrhagic fevers](VHF epidemiology.png)

	* Various hemorrhagic fever viruses are present in worldwide, mostly in the tropics but also North America (Hantavirus), Siberia (Omsk virus), Northern Europe (HFRS)		* Various hemorrhagic fever viruses are present in worldwide, mostly in the tropics but also North America (Hantavirus), Siberia (Omsk virus), Northern Europe (HFRS)

Aidan: Aidan moved page Viral hemorrhagic fevers to Viral hemorrhagic fever

2020-01-23T16:42:41Z

Aidan moved page Viral hemorrhagic fevers to Viral hemorrhagic fever

← Older revision	Revision as of 16:42, 23 January 2020
(No difference)

Aidan at 20:04, 15 August 2019

2019-08-15T20:04:40Z

← Older revision		Revision as of 20:04, 15 August 2019
Line 1:		Line 1:
	= Microbiology =		== Microbiology ==

	* All are negative-sense ssRNA viruses, except for Flaviviridae which are positive-sense ssRNA viruses		* All are negative-sense ssRNA viruses, except for Flaviviridae which are positive-sense ssRNA viruses

	= Species =		== Species ==

	* Family '''Arenaviridae''': typically rodent-associated		* Family '''Arenaviridae''': typically rodent-associated
Line 30:		Line 30:
	** [[Yellow fever virus\|'''Yellow fever''' virus]]		** [[Yellow fever virus\|'''Yellow fever''' virus]]

	= Differential Diagnosis of Hemorrhagic Fever =		== Differential Diagnosis of Hemorrhagic Fever ==

	* Malaria		* Malaria
Line 37:		Line 37:
	* Typhuses, including scrub typhus		* Typhuses, including scrub typhus

	= Epidemiology =		== Epidemiology ==

	![Epidemiology of selected viral hemorrhagic fevers](VHF epidemiology.png)		![Epidemiology of selected viral hemorrhagic fevers](VHF epidemiology.png)
Line 49:		Line 49:
	* Most human infections are associated with agriculture, mining, or military activity		* Most human infections are associated with agriculture, mining, or military activity

	= Pathophysiology =		== Pathophysiology ==

	* Mostly replicate in monocytes, macrophages, and dendritic cells, though some like Ebola and Marburg viruses, can spread to many tissues		* Mostly replicate in monocytes, macrophages, and dendritic cells, though some like Ebola and Marburg viruses, can spread to many tissues
Line 55:		Line 55:
	* Hemorrhagic disease results from inflammation causing vasodilatation and increased permeability, rather than viral infection of the endothelium		* Hemorrhagic disease results from inflammation causing vasodilatation and increased permeability, rather than viral infection of the endothelium

	= Clinical Presentation =		== Clinical Presentation ==

	* Myriad, from asymptomatic to self-limited fever to fatal		* Myriad, from asymptomatic to self-limited fever to fatal
Line 76:		Line 76:
	![Clinical characteristics of selected viral hemorrhagic fevers](VHF clinical characteristics 2.png)		![Clinical characteristics of selected viral hemorrhagic fevers](VHF clinical characteristics 2.png)

	= Case Definitions =		== Case Definitions ==

	== CDC Case Definition ==		=== CDC Case Definition ===

	* CDC has a [https://wwwn.cdc.gov/nndss/conditions/viral-hemorrhagic-fever/case-definition/2011/ case definition (2011)] for VHF caused by Ebola, Lassa, Lujo, or Marburg virus, a New World arenavirus, or Crimean-Congo hemorrhagic fever		* CDC has a [https://wwwn.cdc.gov/nndss/conditions/viral-hemorrhagic-fever/case-definition/2011/ case definition (2011)] for VHF caused by Ebola, Lassa, Lujo, or Marburg virus, a New World arenavirus, or Crimean-Congo hemorrhagic fever
Line 110:		Line 110:
	*** Confirmed: case meets clinical and laboratory criteria		*** Confirmed: case meets clinical and laboratory criteria

	== Public Health Ontario Case Definition ==		=== Public Health Ontario Case Definition ===

	* Case classification		* Case classification
Line 142:		Line 142:
	** Onset may be gradual or acute depending on the type of VHF, with fever, headache, malaise, sore throat, cough, nausea, vomiting, diarrhea, myalgia and chest and abdominal pain. Fever is persistent or spikes intermittently. Inflammation and exudation of the pharynx and conjunctivae are commonly observed.		** Onset may be gradual or acute depending on the type of VHF, with fever, headache, malaise, sore throat, cough, nausea, vomiting, diarrhea, myalgia and chest and abdominal pain. Fever is persistent or spikes intermittently. Inflammation and exudation of the pharynx and conjunctivae are commonly observed.

	= Investigations =		== Investigations ==

	* Rule out malaria and other routine infections		* Rule out malaria and other routine infections
Line 149:		Line 149:
	** Contact both the local public health unit/Medical Officer of Health.		** Contact both the local public health unit/Medical Officer of Health.

	= Diagnosis =		== Diagnosis ==

	* Be careful; inform the Microbiologist/Biochemist before taking or sending samples		* Be careful; inform the Microbiologist/Biochemist before taking or sending samples
Line 155:		Line 155:
	** Usually PCR		** Usually PCR

	= Management =		== Management ==

	* Once a non-Flavivirus viral hemorrhagic fever is suspected, laboratory testing should be minimized		* Once a non-Flavivirus viral hemorrhagic fever is suspected, laboratory testing should be minimized
Line 165:		Line 165:
	* Other treatments are extremely investigative		* Other treatments are extremely investigative

	= Prevention =		== Prevention ==

	* Mostly focusses on good infection control, with isolation of cases		* Mostly focusses on good infection control, with isolation of cases
Line 178:		Line 178:
	* Some experimental vaccines exist		* Some experimental vaccines exist

	= Further Reading =		== Further Reading ==

	* [http://www.cidrap.umn.edu/infectious-disease-topics/vhf Viral hemorrhagic fever (VHF)]. CIDRAP 2012.		* [http://www.cidrap.umn.edu/infectious-disease-topics/vhf Viral hemorrhagic fever (VHF)]. CIDRAP 2012.

Aidan: /* Species */ added links

2019-08-13T17:08:53Z

Species: added links

← Older revision		Revision as of 17:08, 13 August 2019
Line 7:		Line 7:
	* Family '''Arenaviridae''': typically rodent-associated		* Family '''Arenaviridae''': typically rodent-associated
	** Old World viruses		** Old World viruses
	*** Lassa fever		*** [[Lassa virus\|Lassa fever]]
	*** Lujo virus		*** Lujo virus
	** New World viruses		** New World viruses
Line 16:		Line 16:
	*** Sabia virus/Brazilian HF		*** Sabia virus/Brazilian HF
	* Family '''Bunyaviridae''': typically vector-borne		* Family '''Bunyaviridae''': typically vector-borne
	** Rift valley fever (RVF)		** [[Rift valley fever (RVF)]]
	** Crimean Congo hemorrhagic fever (CCHF)		** [[Crimean Congo hemorrhagic fever (CCHF)]]
	* Family '''Filoviridae'''		* Family '''Filoviridae'''
	** Genus '''Marburg virus''' (MARV)		** Genus '''Marburg virus''' (MARV)
	** Genus '''Ebola virus''' (EBOV)		** Genus '''[[Ebola virus]]''' (EBOV)
	*** Bundibugyo ebolavirus (BEBOV)		*** Bundibugyo ebolavirus (BEBOV)
	*** Côte d'Ivoire ebolavirus (CIEBOV)		*** Côte d'Ivoire ebolavirus (CIEBOV)
Line 27:		Line 27:
	*** Reston ebolavirus (REBOV)		*** Reston ebolavirus (REBOV)
	* Family '''Flaviviridae'''		* Family '''Flaviviridae'''
	** '''Dengue''' virus		** [[Dengue virus\|'''Dengue''' virus]]
	** '''Yellow fever'''		** [[Yellow fever virus\|'''Yellow fever''' virus]]

	= Differential Diagnosis of Hemorrhagic Fever =		= Differential Diagnosis of Hemorrhagic Fever =

Aidan: /* Viral hemorrhagic fever */

2019-08-13T17:07:06Z

Viral hemorrhagic fever

← Older revision		Revision as of 17:07, 13 August 2019
Line 1:		Line 1:
	= Viral hemorrhagic fever =

	= Microbiology =		= Microbiology =

Aidan at 17:06, 13 August 2019

2019-08-13T17:06:58Z

← Older revision		Revision as of 17:06, 13 August 2019
Line 1:		Line 1:
	= Viral hemorrhagic fever =		= Viral hemorrhagic fever =

	== Microbiology ==		= Microbiology =

	* All are negative-sense ssRNA viruses, except for Flaviviridae which are positive-sense ssRNA viruses		* All are negative-sense ssRNA viruses, except for Flaviviridae which are positive-sense ssRNA viruses

	== Species ==		= Species =

	* Family '''Arenaviridae''': typically rodent-associated		* Family '''Arenaviridae''': typically rodent-associated
Line 32:		Line 32:
	** '''Yellow fever'''		** '''Yellow fever'''

	== Differential Diagnosis of Hemorrhagic Fever ==		= Differential Diagnosis of Hemorrhagic Fever =

	* Malaria		* Malaria
Line 39:		Line 39:
	* Typhuses, including scrub typhus		* Typhuses, including scrub typhus

	== Epidemiology ==		= Epidemiology =

	![Epidemiology of selected viral hemorrhagic fevers](VHF epidemiology.png)		![Epidemiology of selected viral hemorrhagic fevers](VHF epidemiology.png)
Line 51:		Line 51:
	* Most human infections are associated with agriculture, mining, or military activity		* Most human infections are associated with agriculture, mining, or military activity

	== Pathophysiology ==		= Pathophysiology =

	* Mostly replicate in monocytes, macrophages, and dendritic cells, though some like Ebola and Marburg viruses, can spread to many tissues		* Mostly replicate in monocytes, macrophages, and dendritic cells, though some like Ebola and Marburg viruses, can spread to many tissues
Line 57:		Line 57:
	* Hemorrhagic disease results from inflammation causing vasodilatation and increased permeability, rather than viral infection of the endothelium		* Hemorrhagic disease results from inflammation causing vasodilatation and increased permeability, rather than viral infection of the endothelium

	== Clinical Presentation ==		= Clinical Presentation =

	* Myriad, from asymptomatic to self-limited fever to fatal		* Myriad, from asymptomatic to self-limited fever to fatal
Line 78:		Line 78:
	![Clinical characteristics of selected viral hemorrhagic fevers](VHF clinical characteristics 2.png)		![Clinical characteristics of selected viral hemorrhagic fevers](VHF clinical characteristics 2.png)

	== Case Definitions ==		= Case Definitions =

	=== CDC Case Definition ===		== CDC Case Definition ==

	* CDC has a [https://wwwn.cdc.gov/nndss/conditions/viral-hemorrhagic-fever/case-definition/2011/ case definition (2011)] for VHF caused by Ebola, Lassa, Lujo, or Marburg virus, a New World arenavirus, or Crimean-Congo hemorrhagic fever		* CDC has a [https://wwwn.cdc.gov/nndss/conditions/viral-hemorrhagic-fever/case-definition/2011/ case definition (2011)] for VHF caused by Ebola, Lassa, Lujo, or Marburg virus, a New World arenavirus, or Crimean-Congo hemorrhagic fever
Line 112:		Line 112:
	*** Confirmed: case meets clinical and laboratory criteria		*** Confirmed: case meets clinical and laboratory criteria

	=== Public Health Ontario Case Definition ===		== Public Health Ontario Case Definition ==

	* Case classification		* Case classification
Line 144:		Line 144:
	** Onset may be gradual or acute depending on the type of VHF, with fever, headache, malaise, sore throat, cough, nausea, vomiting, diarrhea, myalgia and chest and abdominal pain. Fever is persistent or spikes intermittently. Inflammation and exudation of the pharynx and conjunctivae are commonly observed.		** Onset may be gradual or acute depending on the type of VHF, with fever, headache, malaise, sore throat, cough, nausea, vomiting, diarrhea, myalgia and chest and abdominal pain. Fever is persistent or spikes intermittently. Inflammation and exudation of the pharynx and conjunctivae are commonly observed.

	== Investigations ==		= Investigations =

	* Rule out malaria and other routine infections		* Rule out malaria and other routine infections
Line 151:		Line 151:
	** Contact both the local public health unit/Medical Officer of Health.		** Contact both the local public health unit/Medical Officer of Health.

	== Diagnosis ==		= Diagnosis =

	* Be careful; inform the Microbiologist/Biochemist before taking or sending samples		* Be careful; inform the Microbiologist/Biochemist before taking or sending samples
Line 157:		Line 157:
	** Usually PCR		** Usually PCR

	== Management ==		= Management =

	* Once a non-Flavivirus viral hemorrhagic fever is suspected, laboratory testing should be minimized		* Once a non-Flavivirus viral hemorrhagic fever is suspected, laboratory testing should be minimized
Line 167:		Line 167:
	* Other treatments are extremely investigative		* Other treatments are extremely investigative

	== Prevention ==		= Prevention =

	* Mostly focusses on good infection control, with isolation of cases		* Mostly focusses on good infection control, with isolation of cases
Line 180:		Line 180:
	* Some experimental vaccines exist		* Some experimental vaccines exist

	== Further Reading ==		= Further Reading =

	* [http://www.cidrap.umn.edu/infectious-disease-topics/vhf Viral hemorrhagic fever (VHF)]. CIDRAP 2012.		* [http://www.cidrap.umn.edu/infectious-disease-topics/vhf Viral hemorrhagic fever (VHF)]. CIDRAP 2012.
	* [https://www.publichealthontario.ca/-/media/documents/guidance-vhf-ontario.pdf?la=en Guidance for Patients with Suspect or Confirmed Viral Haemorrhagic Fevers (VHF) in Acute Care Settings]. Public Health Ontario 2016.		* [https://www.publichealthontario.ca/-/media/documents/guidance-vhf-ontario.pdf?la=en Guidance for Patients with Suspect or Confirmed Viral Haemorrhagic Fevers (VHF) in Acute Care Settings]. Public Health Ontario 2016.

			[[Category:RNA viruses]]

Aidan: Aidan moved page RNA Viral hemorrhagic fever to Viral hemorrhagic fevers without leaving a redirect

2019-08-13T17:06:30Z

Aidan moved page RNA Viral hemorrhagic fever to Viral hemorrhagic fevers without leaving a redirect

← Older revision	Revision as of 17:06, 13 August 2019
(No difference)

Maintenance script: Imported from text file

2019-08-11T18:05:57Z

Imported from text file

New page

= Viral hemorrhagic fever =

== Microbiology ==

* All are negative-sense ssRNA viruses, except for Flaviviridae which are positive-sense ssRNA viruses

== Species ==

* Family '''Arenaviridae''': typically rodent-associated
** Old World viruses
*** Lassa fever
*** Lujo virus
** New World viruses
*** Junin virus/Argentine HF
*** Machupo virus/Bolivian HF
*** Chapare virus
*** Guanarito virus/Venezuelan HF
*** Sabia virus/Brazilian HF
* Family '''Bunyaviridae''': typically vector-borne
** Rift valley fever (RVF)
** Crimean Congo hemorrhagic fever (CCHF)
* Family '''Filoviridae'''
** Genus '''Marburg virus''' (MARV)
** Genus '''Ebola virus''' (EBOV)
*** Bundibugyo ebolavirus (BEBOV)
*** Côte d'Ivoire ebolavirus (CIEBOV)
*** Reston ebolavirus (REBOV)
*** Sudan ebolavirus (SEBOV)
*** Reston ebolavirus (REBOV)
* Family '''Flaviviridae'''
** '''Dengue''' virus
** '''Yellow fever'''

== Differential Diagnosis of Hemorrhagic Fever ==

* Malaria
* Enteric fever
* Bacteremia
* Typhuses, including scrub typhus

== Epidemiology ==

![Epidemiology of selected viral hemorrhagic fevers](VHF epidemiology.png)

* Various hemorrhagic fever viruses are present in worldwide, mostly in the tropics but also North America (Hantavirus), Siberia (Omsk virus), Northern Europe (HFRS)
* Zoonotic viruses with reservoirs that include rodents (especially Arenaviridae), livestock, primates, birds, etc.
** Humans are generally end hosts
* Some (especially Bunyaviridae and Flaviviridae) are tick-borne, others are mosquito-borne
** Many can be transmitted person-to-person through secretions and blood
** A few cannot be transmitted person-to-person: dengue, yellow fever, and Rift Valley fever
* Most human infections are associated with agriculture, mining, or military activity

== Pathophysiology ==

* Mostly replicate in monocytes, macrophages, and dendritic cells, though some like Ebola and Marburg viruses, can spread to many tissues
* Host response at least in part determines severity of disease
* Hemorrhagic disease results from inflammation causing vasodilatation and increased permeability, rather than viral infection of the endothelium

== Clinical Presentation ==

* Myriad, from asymptomatic to self-limited fever to fatal
* Early symptoms typically include fever, malaise, myalgias, and headache
** Fever is typically high and unremitting
* Severe abdominal pain
* Vomiting and diarrhea, especially in Filoviridae
* Bleeding is rarely a presenting symptom
* On examination, may have diffuse blanchable erythema on the upper body from capillary dilatation, conjunctival injection with petechial hemorrhages, or an erythematous rash (early Marburg, Ebola, CCHF, and dengue)
** Edema of face and extremities, especially in Lassa fever
* Filoviridae and Yellow fever: bradycardia
* Arenaviridae: pharyngitis, retrosternal chest pain, and proteinuria
* Mortality depends on the specific infection
* After resolution of symptoms, can still have virus present in privileged sites (eye, CNS, mammary gland, and male genitourinary tract)
** They will still be infectious for months after resolution
** They may have a recurrence or relapse of disease from these sites, which may be limited (e.g. uveitis or meningitis alone)

![Clinical characteristics of selected viral hemorrhagic fevers](VHF clinical characteristics 1.png)

![Clinical characteristics of selected viral hemorrhagic fevers](VHF clinical characteristics 2.png)

== Case Definitions ==

=== CDC Case Definition ===

* CDC has a [https://wwwn.cdc.gov/nndss/conditions/viral-hemorrhagic-fever/case-definition/2011/ case definition (2011)] for VHF caused by Ebola, Lassa, Lujo, or Marburg virus, a New World arenavirus, or Crimean-Congo hemorrhagic fever
** Clinical criteria: acute onset of both of the following
*** Fever >40º C
*** One or more of:
**** Severe headache
**** Muscle pain
**** Erythematous maculopapular rash on the trunk with fine desquamation 3–4 days after rash onset
**** Vomiting
**** Diarrhea
**** Pharyngitis (arenavirus only)
**** Abdominal pain
**** Bleeding not related to injury
**** Retrosternal chest pain (arenavirus only)
**** Proteinuria (arenavirus only)
**** Thrombocytopenia
** Laboratory criteria: one of more of the following
*** Detection of viral hemorrhagic fever (VHF) viral antigens in blood by enzyme-linked Immunosorbent Assay (ELISA) antigen detection
*** VHF viral isolation in cell culture for blood or tissues
*** Detection of VHF-specific genetic sequence by Reverse Transcription-Polymerase Chain Reaction (RT-PCR) from blood or tissues
*** Detection of VHF viral antigens in tissues by immunohistochemistry
** Epidemiologic linkage: one or more of the following exposures within 3 weeks of symptoms
*** Contact with blood or other body fluids of a patient with VHF
*** Residence in—or travel to—a VHF endemic area
*** Work in a laboratory that handles VHF specimens
*** Work in a laboratory that handles bats, rodents, or primates from endemic areas
*** Exposure to semen from a confirmed acute or convalescent case of VHF within the 10 weeks of that person's onset of symptoms
** Case classification
*** Suspected: case meets clinical and epidemiologic linkage criteria
*** Confirmed: case meets clinical and laboratory criteria

=== Public Health Ontario Case Definition ===

* Case classification
** Confirmed case: clinically compatible signs and symptoms and at least two of the hemorrhagic manifestations, and laboratory confirmation of infection
** Probable case: clinically compatible signs and symptoms and at least one of the hemorrhagic manifestations, and a history within the last 3 weeks of fever one of the following
*** Travel in a specific area of a country where an outbreak of viral hemorrhagic fever (VHF) has recently occurred
*** An epidemiologic link with a confirmed and/or probable case of VHF
*** Direct contact with blood or other body fluids from a confirmed or probable case of VHF
*** Work in a laboratory that handles VHF virus specimens or in a facility that handles animals with VHF
* Laboratory criteria
** Any of the following
*** Isolation and identification of virus from an appropriate clinical specimen (e.g., blood, serum, tissue, urine specimens or throat secretions) (performed at the National Microbiology Laboratory);
*** Detection of virus-specific RNA by reverse-transcriptase PCR from an appropriate clinical specimen (e.g., blood, serum, tissue) using two independent targets or two independent samples AND confirmed by the National Microbiology Laboratory by nucleic acid testing or serology;
*** Demonstration of virus antigen in tissue (e.g., skin, liver or spleen) by immunohistochemical or immunofluorescent techniques AND another test (e.g., PCR);
*** Demonstration of specific IgM AND IgG antibody by EIA, immunofluorescent assay or Western Blot by the National Microbiology Laboratory or an approved WHO collaboration centre
*** Demonstration of a fourfold rise in IgG titre by EIA, immunofluorescent assay from an acute vs. a convalescent serum sample (performed at the National Microbiology Laboratory).
** Validated tests
*** Culture
*** NAAT (RT-PCR)
*** Antigen detection
*** IgM and IgG serology
* Clinical criteria
** Any 2 of the following hemorrhagic manifestations (from WHO recommended surveillance standards, 1999):
*** Hemorrhagic or purpuric rash
*** Epistaxis
*** Hematemesis
*** Hemoptysis
*** Blood in stools
*** Other hemorrhagic symptom and no known predisposing host factors for hemorrhagic manifestations
** Sign and symptoms consistent with the following: Lassa, Junin, Machupo, Sabia, Guanarito (arenaviruses); Crimean Congo, Rift Valley fever (bunyaviruses); Ebola, Marburg (filoviruses); Dengue fever, Yellow fever, Omsk hemorrhagic fever, Kyasanur Forest Disease (flaviviruses).
** Onset may be gradual or acute depending on the type of VHF, with fever, headache, malaise, sore throat, cough, nausea, vomiting, diarrhea, myalgia and chest and abdominal pain. Fever is persistent or spikes intermittently. Inflammation and exudation of the pharynx and conjunctivae are commonly observed.

== Investigations ==

* Rule out malaria and other routine infections
* '''Before collecting appropriate specimens for investigation of suspected VHF, the clinician must:'''
** Consult with a Public Health Ontario Laboratory (PHOL) microbiologist available through the PHOL Customer Service Centre at 416-235-6556 or toll free at 1-877-604-4567.
** Contact both the local public health unit/Medical Officer of Health.

== Diagnosis ==

* Be careful; inform the Microbiologist/Biochemist before taking or sending samples
* Diagnostic testing includes culture, PCR, antigen detection, and serology
** Usually PCR

== Management ==

* Once a non-Flavivirus viral hemorrhagic fever is suspected, laboratory testing should be minimized
** Most hemorrhagic fever viruses are biosafety level 3 or 4
* Management is largely supportive
** Fluid and electrolyte management: patients often need significant volume resuscitation due to third-spacing from increased vascular permeability
** Manage coagulopathy with cryoprecipitate, FFP, and platelets as needed
* Ribavirin may have activity against Lassa fever, New World Arenaviridae, and Rift Valley fever
* Other treatments are extremely investigative

== Prevention ==

* Mostly focusses on good infection control, with isolation of cases
** Enveloped viruses, so more susceptible to detergents, alcohol, etc.
** Routine infection control practices with all patients
** Additional precautions for Filoviridae (e.g. Ebola, Marburg) or Arenaviridae (e.g. Lassa, Machupo, Junin) families or due to Crimean-Congo hemorrhagic fever virus
*** Contact and droplet precautions with lots of PPE and a dedicated single-patient room
*** Should be kept in negative-pressure isolation with airborne precautions if any signs of respiratory disease
* Nosocomial exposures
** Healthcare workers with a high-risk (i.e. fluid-on-membrane) exposure should be monitored for 21 days
** Could consider Ebola (and other experimental) vaccine as post-exposure prophylaxis
* Some experimental vaccines exist

== Further Reading ==

* [http://www.cidrap.umn.edu/infectious-disease-topics/vhf Viral hemorrhagic fever (VHF)]. CIDRAP 2012.
* [https://www.publichealthontario.ca/-/media/documents/guidance-vhf-ontario.pdf?la=en Guidance for Patients with Suspect or Confirmed Viral Haemorrhagic Fevers (VHF) in Acute Care Settings]. Public Health Ontario 2016.